No experience
Employment Type:
Full time
Job Category:
Information Services
Summer 2018 Software Engineer Interns
(This job is no longer available)
23andMe, Inc. | Mountain View, CA
Grad Date

Not sure what types of jobs you are interested in?

Explore Jobs
Based on Your Education

Follow This Company

Job Description

Software engineering students of all levels wanted for our software intern opportunity! Come join us in our mission to be the world's trusted source of personal genetic information. Full-time internships will be offered for 12 weeks.

You'll have the opportunity to solve challenging engineering problems that come with building a highly interactive website and manipulating large amounts of data in the background. You'll work within a small, fast-paced team that has a mix of veteran engineers and recent graduates to work on a variety of tasks.

What you'll do

We have opportunities in big data software development team. You'll be involved in design and implementation of new features and frameworks, participate in our product development process, write unit and functional tests, and solve performance and scalability problems.

What you'll bring

You're just graduating with your Bachelor's degree or working on your Master's degree in Computer Science or related major. You have strong applied experience. You've built, broken, rebuilt software applications. You have the ability to deliver well-designed high-quality code on time.

Preferred skillset: Solid software development background, can-do attitude, and a great team player.

About you

* You're curious, excited by new technologies, and thrive in a fast-paced and high impact environment.
* You are self-motivated to work and achieve, and you are also a great collaborator on teams.
* You are crazy smart and love working with others you can learn from.
* Your idea of fun is to be challenged by hard problems. You love to think outside the box and build things that make an impact on people around the world every day.

About Us

23andMe, Inc. is the leading consumer genetics and research company. Our mission is to help people access, understand and benefit from the human genome. The company was named by MIT Technology Review to its "50 Smartest Companies, 2017" list, and named one of Fast Company's "25 Brands That Matter Now, 2017". 23andMe has millions of customers worldwide, with ~85 percent of customers consented to participate in research. 23andMe is located in Mountain View, CA. More information is available at www.23andMe.com.

At 23andMe we value a diverse, inclusive work force and we provide equal employment opportunity for all applicants and employees. All qualified applicants for employment will be considered without regard to an individual's race, color, sex, gender identity, gender expression, religion, age, national origin or ancestry, citizenship, physical or mental disability, medical condition, family care status, marital status, domestic partner status, sexual orientation, genetic information, military or veteran status, or any other basis protected by federal, state or local laws. 23andMe will reasonably accommodate qualified individuals with disabilities to the extent required by applicable law.

Please note: 23andMe does not accept agency resumes and we are not responsible for any fees related to unsolicited resumes. Thank you.

About 23andMe, Inc.

We support the Subcommittee and FDA in the effort to create an improved regulatory framework for genetic testing. We are already working with FDA, NIH, and other organizations to strengthen regulations for all laboratory testing, including genetic testing. Indeed, we first met with the FDA in 2007, before we ever offered our service to consumers. Thereafter, in 2008, we met with FDA Commissioner von Eschenbach and his staff, and they encouraged us to proceed. We have had ongoing discussions with FDA since that time. Tomorrow, we will present our regulatory proposal to the FDA. Our plan takes into account rapid technological innovation and ensures the analytical and clinical validity of all laboratory tests. In addition, we think new regulations should provide transparency across the industry so that consumers know what they are getting from the services they choose. At the heart of any new regulations should be the requirement that DTC genetic companies operate at the highest levels of science and ethics. 23andMe grounds its service in several core elements: informed consent and strong privacy protections; educating customers about personal considerations they should take into account when using our service; educating customers and providing full transparency about the science behind our service; and recommending that, if customers have questions about their results, they should coordinate with their physicians or a genetic counselor. Indeed, we are proud that, in 2008, our company's DNA-testing service was selected by TIME Magazine as the number one "Invention of the Year." One of 23andMe's core missions is the development of innovative solutions for accelerating genetic research. Our database is one of the largest collections of genetic and health information in existence, and has already led to published discoveries. We are currently working with the Parkinson's Institute on research aimed at discovering the genetic factors underlying Parkinson's disease. We are proud to have with us today the head of the Parkinson's Institute, Dr. William Langston, one of the leading Parkinson's researchers in America. We appreciate the concerns that people who receive DTC genetic information could make harmful decisions without consulting a physician, or could be lulled into inaction based on their results. However, we have seen neither data nor scientific literature to support this view. Indeed, the current scientific literature, combined with our own experience, shows that people do not take rash or unconsidered actions. Moreover, 23andMe's service is consistent with the FDA's long history of approving at-home, over-the-counter laboratory tests for HIV, hepatitis, and other diseases, in addition to permitting consumers direct access to tests for other conditions, such as high cholesterol and pregnancy. We believe the current regulatory landscape is ready for improvement, and we welcome your interest and leadership in this area. Thank you, and I look forward to your questions.